| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30053672 | HIV | ENSG00000198900.7 | protein_coding | TOP1 | Yes | No | 7150 | P11387 |
| TVIS20018930 | HPV | ENSG00000198900.7 | protein_coding | TOP1 | Yes | No | 7150 | P11387 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | TOP1 |
|---|---|
| DrugBank ID | DB06159 |
| Drug Name | Rubitecan |
| Target ID | BE0000971 |
| UniProt ID | P11387 |
| Regulation Type | |
| PubMed IDs | 16193332 |
| Citations | Chedid S, Rivera E, Frye DK, Ibrahim N, Esteva F, Valero V, Hortobagyi G, Mettinger KL, Cristofanilli M: Minimal clinical benefit of single agent Orathecin (Rubitecan) in heavily pretreated metastatic breast cancer. Cancer Chemother Pharmacol. 2006 Apr;57(4):540-4. Epub 2005 Sep 29. |
| Groups | Investigational |
| Direct Classification | |
| SMILES | CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=CC=C(C1=C3)[N+]([O-])=O)C2=O |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL77305 |
